The company booked total revenues of 57.92 million lei in the first three months of 2008.
Expenses inched 3 percent to 51.04 million lei on the similar period of last year.
The drug maker reconfirmed the results previously announced at the beginning of April. Thus, the net profit rallied 50 percent in the first three months to 10.56 million lei and business advanced 19 percent to 57.65 million lei.
The company has a share capital of 45.49 million lei, divided into 454.9 million shares at a face value of 0.10 lei. The majority owner is the state assets recovery body AVAS which controls a 53.02 percent stake. Financial company SIF Oltenia (SIF5) holds a 10.10 percent chunk.
In lipsa unui acord scris din partea InternetCorp, puteti prelua maxim 500 de caractere din acest articol daca precizati sursa si daca inserati vizibil linkul articolului Antibiotice Iasi reports revenues up 10% yoy in Q1.